• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 10, Issue 2
  3. Author

Online ISSN: 2515-8260

Volume10, Issue2

A clinical study of comparison of maternal and fetal outcome between primigravida and multigravida women with placenta previa admitted at a tertiary care centre in Vellore, Tamil Nadu: A prospective cohort study

    Dr. K Lavanya, Dr. V Rekha, Dr. Uthra KG, Dr. Suganya Asaithambi

European Journal of Molecular & Clinical Medicine, 2023, Volume 10, Issue 2, Pages 2092-2105

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Placenta Previa is the complete or partial covering of the internal os of the cervix with placenta. It is the major risk factor for postpartum haemorrhage and lead to morbidity and mortality of the mother and new born. Uncontrolled postpartum hemorrhage from placenta previa and PAS (placenta accreta spectrum may necessitate need for blood transfusion, hysterectomy, ICU admissions and even death.
Aim: To compare the maternal and fetal outcome between primigravida and multigravida women with placenta previa admitted in Government Vellore Medical College, Tamil Nadu.
Results: The incidence of placenta previa was highest among the following age groups
20-29yrs i.e.67.32%, most common risk factors are caesarean section 45.5%(1 LSCS-30%, 2LSCS-16%), 1 bleeding episode cases-78% followed by 15% of cases has 2 episodes of bleeding,79% of cases in our study participants had cephalic presentation followed by breech 16% followed by transverse lie 5%,Type 2A Placenta previa had 46%, Type 2B placenta previa had 18%,Type 3 Placenta previa 16%,Type 4-11% Lowest incidence.
Type 1 placenta previa 9%, 82% of cases underwent emergency LSCS, 50% of cases underwent prophylactic uterine artery ligation, 32% of cases had PPH managed medically and surgically, 9% of cases underwent elective LSCS, for all 9 cases prophylactic uterine artery ligation done, no postpartum hemorrhage.
Type 2A placenta previa - 46 cases (6 cases elective LSCS, 40 cases emergency LSCS) 15 cases had foley tamponade with uterine artery ligation, 12% cases had foley tamponade, 1 cases underwent subtotal hysterectomy).
Type 2B placenta previa -18 cases (2 cases elective lscs, 16 cases emergency lscs) 9 cases had foley tamponade with uterine artery ligation, 4 cases had uterine artery ligation, 2cases had uterine artery ligation with B lynch).
Type 4 placenta Previa, 11 cases (emergency lscs), 5 cases – Foley with uterine artery ligation, 3 cases total hysterectomy, 1 case subtotal hysterectomy1 bladder repair.
Out of 9 perinatal deaths, Asphyxia and prematurity were major contributions 4.3% and 2.6% respectively followed by RDS1.6%) Neonatal mortality was 8-9% with placenta previa. Perinatal death were higher in gestational age between 30-33 weeks.
Keywords:
    placenta previa postpartum hemorrhage caesarean hysterectomy blood transfusion perinatal morbidity and mortality
  • PDF (355 K)
  • XML
(2023). A clinical study of comparison of maternal and fetal outcome between primigravida and multigravida women with placenta previa admitted at a tertiary care centre in Vellore, Tamil Nadu: A prospective cohort study. European Journal of Molecular & Clinical Medicine, 10(2), 2092-2105.
Dr. K Lavanya, Dr. V Rekha, Dr. Uthra KG, Dr. Suganya Asaithambi. "A clinical study of comparison of maternal and fetal outcome between primigravida and multigravida women with placenta previa admitted at a tertiary care centre in Vellore, Tamil Nadu: A prospective cohort study". European Journal of Molecular & Clinical Medicine, 10, 2, 2023, 2092-2105.
(2023). 'A clinical study of comparison of maternal and fetal outcome between primigravida and multigravida women with placenta previa admitted at a tertiary care centre in Vellore, Tamil Nadu: A prospective cohort study', European Journal of Molecular & Clinical Medicine, 10(2), pp. 2092-2105.
A clinical study of comparison of maternal and fetal outcome between primigravida and multigravida women with placenta previa admitted at a tertiary care centre in Vellore, Tamil Nadu: A prospective cohort study. European Journal of Molecular & Clinical Medicine, 2023; 10(2): 2092-2105.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 10
  • PDF Download: 40
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus